Meeting Abstract

Effectiveness of Different Dosages of Retreatment of Rituximab in Combination with Leflunomide: Results from a Multicenter Randomized Placebo Controlled Investigator Initiated Clinical Trial in Active Rheumatoid Arthritis (Amara-Study


AutorenlisteBehrens, Frank; Rossmanith, Tanja; Koehm, Michaela; Alten, Rieke; Aringer, Martin; Burmester, G. R.; Feist, Eugen; Krueger, Klaus; Mueller-Ladner, Ulf; Rubbert-Roth, Andrea; Wassenberg, Siegfried; Tony, Hans-Peter; Kellner, Herbert; Backhaus, Marina; Burkhardt, Harald

Jahr der Veröffentlichung2016

ZeitschriftArthritis & Rheumatology

Bandnummer68

ISSN2326-5191

eISSN2326-5205

KonferenzAnnual Meeting of the American-College-of-Rheumatology/Association-of-Rheumatology-Health-Professionals (ACR/ARHP)

VerlagWiley



Zitierstile

Harvard-ZitierstilBehrens, F., Rossmanith, T., Koehm, M., Alten, R., Aringer, M., Burmester, G., et al. (2016) Effectiveness of Different Dosages of Retreatment of Rituximab in Combination with Leflunomide: Results from a Multicenter Randomized Placebo Controlled Investigator Initiated Clinical Trial in Active Rheumatoid Arthritis (Amara-Study, Arthritis & Rheumatology, 68

APA-ZitierstilBehrens, F., Rossmanith, T., Koehm, M., Alten, R., Aringer, M., Burmester, G., Feist, E., Krueger, K., Mueller-Ladner, U., Rubbert-Roth, A., Wassenberg, S., Tony, H., Kellner, H., Backhaus, M., & Burkhardt, H. (2016). Effectiveness of Different Dosages of Retreatment of Rituximab in Combination with Leflunomide: Results from a Multicenter Randomized Placebo Controlled Investigator Initiated Clinical Trial in Active Rheumatoid Arthritis (Amara-Study. Arthritis & Rheumatology. 68.


Zuletzt aktualisiert 2025-02-04 um 01:44